Goldman Sachs analyst Rajan Sharma maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £16.80.
Goldman Sachs Group Inc. is scrapping a pledge it made to refuse initial public offering (IPO) business from companies that ...
Goldman Sachs isn't the only company that previously defended its DEI program from anti-DEI critics. Deutsche Bank CEO ...
A growing number of prominent companies have scaled back or set aside the diversity, equity and inclusion initiatives that ...
US President Donald Trump has demolished the DEI industry in America. The acronym, which stands for diversity, equity and ...
President Donald Trump could sign an order as soon as Wednesday to require that U.S. tariffs on imports match the tax rates ...
Major corporations including Google, Amazon, McDonald’s, Boeing and IBM have significantly scaled back their diversity, ...
Missouri accused Starbucks of tying executive pay to the company’s achieving racial and gender-based hiring quotas.
NEW YORK >> Starbucks was sued today by the state of Missouri, which accused the coffee chain of using a commitment to diversity, equity and inclusion as a pretext to systemically discriminate based ...
NEW YORK (Reuters) - Starbucks was sued on Tuesday by the U.S. state of Missouri, which accused the coffee chain of using a ...
A group of 17 Republican state attorneys general are demanding answers from top asset managers, who they say are misleading ...
As high-profile brands like Target, Walmart, McDonald's and Meta scale back their DEI commitments-sparking backlash and boycotts-many companies are ...